Penumbra Inc

NYSE: PEN
$240.87
+$0.38 (+0.2%)
Real Time Data Delayed 15 Min.

PEN Stock Chart and Intraday Price

PEN Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address ONE PENUMBRA PLACE, ALAMEDA, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 9,160.01M USD
Shares Outstanding 38,703,700
Penumbra Inc is a pioneering medical device company based in Alameda, California, specializing in innovative solutions for neurovascular and peripheral vascular conditions. Its product lineup includes the Indigo System for clot removal, various thrombectomy systems like Lightning Flash and Lightning Bolt 7, and the Penumbra System for mechanical thrombectomy. Additionally, Penumbra offers neuro embolization coils, peripheral embolization products, and cutting-edge neurosurgical tools. With a focus on improving patient outcomes, Penumbra's products are distributed globally, serving healthcare professionals and patients with advanced medical technology since 2004.

PEN Articles

Friday's top analyst upgrades and downgrades included Analog Devices, Boston Scientific, CrowdStrike, Enphase Energy, Frontier, International Paper, Nike, Petrobras, Truist Financial and VICI...
Wednesday's top analyst upgrades and downgrades included Array Technology, Blink Charging, Carnival, Carrier Global, DocuSign, Fox, Marathon Petroleum, Occidental Petroleum, PagSeguro Digital,...
Monday's top analyst upgrades and downgrades included Altice USA, Arista Networks, Block, Cardinal Health, ConocoPhillips, Datadog, GoodRx, Monster Beverage, PepsiCo, Spirit AeroSystems, Twilio and...